Steven Cohen Kodiak Sciences Inc. Transaction History
Point72 Asset Management, L.P.
- $40.1 Billion
- Q1 2025
A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Kodiak Sciences Inc. stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 1,072,418 shares of KOD stock, worth $3.55 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,072,418
Previous 523,751
104.76%
Holding current value
$3.55 Million
Previous $5.21 Million
42.18%
% of portfolio
0.01%
Previous 0.01%
Shares
5 transactions
Others Institutions Holding KOD
# of Institutions
108Shares Held
41.3MCall Options Held
10.9KPut Options Held
700-
Baker Bros. Advisors LP New York, NY17.3MShares$57.3 Million0.58% of portfolio
-
Black Rock Inc. New York, NY3.85MShares$12.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.69MShares$5.59 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA1.53MShares$5.07 Million0.04% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA1.33MShares$4.39 Million0.01% of portfolio
About Kodiak Sciences Inc.
- Ticker KOD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,040,200
- Market Cap $172M
- Description
- Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...